Accordingly, in HL patients we identified DLX1, EMX2, NKX2-2 and NKX3-2, in DLBCL we found NKX2-1, and HCL patients expressed BARX2 (Table 1). This evidence concerns the gene NKX3-2 and Hodgkins lymphoma.